Delayed Antiretroviral Therapy (ART) Initiation among Hospitalized Adults in a Resource-Limited Settings: A Challenge to the Global Target of ART for 90% of HIV-Infected Individuals.

IF 1.1 Q4 INFECTIOUS DISEASES
AIDS Research and Treatment Pub Date : 2019-04-01 eCollection Date: 2019-01-01 DOI:10.1155/2019/1832152
Prossie Merab Ingabire, Fred Semitala, Moses R Kamya, Damalie Nakanjako
{"title":"Delayed Antiretroviral Therapy (ART) Initiation among Hospitalized Adults in a Resource-Limited Settings: A Challenge to the Global Target of ART for 90% of HIV-Infected Individuals.","authors":"Prossie Merab Ingabire, Fred Semitala, Moses R Kamya, Damalie Nakanjako","doi":"10.1155/2019/1832152","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Combination antiretroviral therapy (cART) initiation in hospital settings, where individuals often present with undiagnosed, untreated, advanced HIV disease, is not well understood.</p><p><strong>Methods: </strong>A cross-sectional study was conducted to determine a period prevalence of cART initiation within two weeks of eligibility, as determined at hospitalization. Using a pretested and precoded data extraction tool, data on cART initiation status and reason for not initiating cART was collected. Phone calls were made to patients that had left the hospital by the end of the two-week period. Delayed cART initiation was defined as failure to initiate cART within two weeks. Sociodemographic characteristics, WHO clinical stage, CD4 count, cART initiation status, and reasons for delayed cART initiation were extracted and analyzed.</p><p><strong>Results: </strong>Overall, 386 HIV-infected adults were enrolled, of whom 289/386 (74.9%) had delayed cART initiation, 77/386 (19.9%) initiated cART, and 20/386 (5.2%) were lost-to-follow-up, within two weeks of cART eligibility. Of 289 with delayed ART initiation, 94 (32.5%) died within two weeks of cART eligibility. Patients with a CD4 cell count≥ 50 cells/<i>μ</i>l and who resided in ≥8 kilometers from the hospital were more likely to have delayed cART initiation [adjusted odds ratio (AOR) 2.34, 95% CI: 1.33-4.10, p value 0.003; and AOR 1.92, 95% CI: 1.09-3.40, p value 0.025; respectively].</p><p><strong>Conclusion: </strong>Up to 75% of hospitalized HIV-infected, cART-naïve, cART-eligible patients did not initiate cART and had a 33% pre-ART mortality rate within two weeks of eligibility for cART. Hospital based strategies to hasten cART initiation during hospitalization and electronic patient tracking systems could promote active linkage to HIV treatment programs, to prevent HIV/AIDS-associated mortality in resource-limited settings.</p>","PeriodicalId":46303,"journal":{"name":"AIDS Research and Treatment","volume":"2019 ","pages":"1832152"},"PeriodicalIF":1.1000,"publicationDate":"2019-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6463639/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"AIDS Research and Treatment","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1155/2019/1832152","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2019/1/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Combination antiretroviral therapy (cART) initiation in hospital settings, where individuals often present with undiagnosed, untreated, advanced HIV disease, is not well understood.

Methods: A cross-sectional study was conducted to determine a period prevalence of cART initiation within two weeks of eligibility, as determined at hospitalization. Using a pretested and precoded data extraction tool, data on cART initiation status and reason for not initiating cART was collected. Phone calls were made to patients that had left the hospital by the end of the two-week period. Delayed cART initiation was defined as failure to initiate cART within two weeks. Sociodemographic characteristics, WHO clinical stage, CD4 count, cART initiation status, and reasons for delayed cART initiation were extracted and analyzed.

Results: Overall, 386 HIV-infected adults were enrolled, of whom 289/386 (74.9%) had delayed cART initiation, 77/386 (19.9%) initiated cART, and 20/386 (5.2%) were lost-to-follow-up, within two weeks of cART eligibility. Of 289 with delayed ART initiation, 94 (32.5%) died within two weeks of cART eligibility. Patients with a CD4 cell count≥ 50 cells/μl and who resided in ≥8 kilometers from the hospital were more likely to have delayed cART initiation [adjusted odds ratio (AOR) 2.34, 95% CI: 1.33-4.10, p value 0.003; and AOR 1.92, 95% CI: 1.09-3.40, p value 0.025; respectively].

Conclusion: Up to 75% of hospitalized HIV-infected, cART-naïve, cART-eligible patients did not initiate cART and had a 33% pre-ART mortality rate within two weeks of eligibility for cART. Hospital based strategies to hasten cART initiation during hospitalization and electronic patient tracking systems could promote active linkage to HIV treatment programs, to prevent HIV/AIDS-associated mortality in resource-limited settings.

Abstract Image

Abstract Image

在资源有限的环境中,住院成人的延迟抗逆转录病毒治疗(ART)启动:对90%HIV感染者的ART全球目标的挑战。
背景:在医院环境中,联合抗逆转录病毒疗法(cART)的启动尚不清楚,因为在医院环境下,患者往往患有未确诊、未经治疗的晚期HIV疾病。方法:进行一项横断面研究,以确定在符合条件的两周内开始cART的时期流行率,如在住院时确定的。使用预测试和预编码的数据提取工具,收集关于cART启动状态和未启动cART的原因的数据。他们给两周结束时出院的病人打了电话。延迟启动cART被定义为两周内未能启动cART。提取并分析了社会形态特征、世界卫生组织临床分期、CD4计数、cART启动状态以及cART启动延迟的原因。结果:总体而言,386名HIV感染的成年人被纳入,其中289/386(74.9%)延迟了cART启动,77/386(19.9%)启动了cART,20/386(5.2%)在符合cART资格的两周内失去了随访。289例延迟启动抗逆转录病毒疗法的患者中,94例(32.5%)在符合cART条件的两周内死亡。CD4细胞计数≥50个细胞/μl且居住在距离医院≥8公里的患者更有可能延迟cART启动[调整比值比(AOR)分别为2.34,95%CI:1.33-4.10,p值0.003;AOR分别为1.92,95%CI:1.09-3.40,p值0.025]。结论:高达75%的住院HIV感染者,符合cART条件的患者没有启动cART,并且在符合cART资格的两周内ART前死亡率为33%。基于医院的在住院期间加速cART启动的策略和电子患者跟踪系统可以促进与HIV治疗计划的积极联系,以防止在资源有限的环境中与HIV/AIDS相关的死亡。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
AIDS Research and Treatment
AIDS Research and Treatment INFECTIOUS DISEASES-
CiteScore
3.10
自引率
0.00%
发文量
13
审稿时长
18 weeks
期刊介绍: AIDS Research and Treatment is a peer-reviewed, Open Access journal that publishes original research articles, review articles, and clinical studies focused on all aspects of HIV and AIDS, from the molecular basis of disease to translational and clinical research. In addition, articles relating to prevention, education, and behavior change will be considered
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信